Massive public investment has gone into developed Covid-19 vaccines, and patents on vaccines must be waived to ensure they are not treated like a commodity, says Visiting Policy Fellow Els Torreele (Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø Institute for Innovation & Public Purpose).
,